Bladder Cancer Trial, Recruiting NCT06287541 Sponsor: The First Affiliated Hospital with Nanjing Medical University Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT06287541
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with non-muscle-invasive bladder cancer (a type of bladder cancer that has not spread into the bladder muscle) and have already had a first surgical procedure to remove the tumour, with a second similar procedure planned
  • People whose urine tests for certain biological markers came back negative after the first surgery but before the second surgery
  • People aged 18 years or older
  • People who are willing to share their basic health information, tissue test results, and follow-up monitoring data with the trial team
  • People who are willing to sign a form agreeing to take part in the study

Who may not be able to join:

  • People who have been diagnosed with other cancers that are not bladder-lining cancers, including prostate cancer or kidney cancer
  • People who have previously been diagnosed with bladder cancer that had spread into the bladder muscle
  • People who are not able to undergo the second surgical procedure
  • People whose tissue sample test results are incomplete
  • People who have any condition that the research team believes could put them at risk or prevent them from completing the study requirements (confirm with trial site)
  • People who are not able to provide written agreement to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 July 2023
Est. completion
1 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

2-year RFS rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov